Epigenetic advances in rheumatic heart disease

风湿性心脏病表观遗传学进展

阅读:2

Abstract

Rheumatic heart disease (RHD), an autoimmune injury triggered by group A streptococcus (GAS) infection, exerts a significant pathological impact on the human heart. The pathogenesis of RHD is closely associated with abnormal epigenetic regulation, and primarily involves the four core epigenetic mechanisms: DNA methylation, histone modification, non-coding RNAs (ncRNAs), and chromatin remodeling. Currently, researches on RHD have shifted from focusing on late-stage diagnosis and treatment to investigating its multiple etiologies. Therefore, this article presents a systematic literature review aimed at reviewing the latest progress in the epigenetic research of RHD, providing in-depth elucidation of the interactions between RHD and these four core mechanisms, highlighting the value of potential biomarkers for the disease's early diagnosis and treatment, and outlining future research directions, including combined multi-omics analysis, minimally invasive interventional techniques, and gene chip-based approaches. This review aims to address the limitations of single-subject studies and small-sample cross-sectional surveys in epigenetic studies of RHD, thereby providing new strategies for disease prevention, control, and health management.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。